KNG1
KNG1 (kininogen 1, also known as BK, HMWK, KNG, BDK and HK) is a secreted protein that gives rise to high and low molecular weight kininogen. High molecular weight kininogen is a source of bradykinin and is essential for blood coagulation and the kallikrein-kinin system. Browse Assay Genie's current range of KNG1 research reagents below, or read on for the biology behind the target.
The KNG1 gene uses alternative splicing to generate two different proteins: high molecular weight kininogen (HMWK) and low molecular weight kininogen (LMWK). HMWK is essential for blood coagulation and for assembly of the kallikrein-kinin system. LMWK, in contrast, is not involved in blood coagulation. Bradykinin, a peptide with numerous physiological effects, is released from HMWK.
Bradykinin is a potent vasodilator. According to UniProt, it influences smooth muscle contraction, induces hypotension, promotes natriuresis and diuresis, and decreases blood glucose level. It is also a mediator of inflammation, increasing vascular permeability, stimulating nociceptors and triggering the release of other inflammatory mediators such as prostaglandins. It has a cardioprotective effect, acting directly and indirectly through endothelium-derived relaxing factor. NCBI Gene adds that bradykinin also functions as an antimicrobial peptide with antibacterial and antifungal activity.
The KNG1 protein is secreted into the extracellular space. HGNC classifies the gene within the type 3 cystatins and the neuropeptides, and lists the previous name "kininogen". Three transcript variants encoding different isoforms have been described. Infection with SARS-CoV-2 reduces or depletes angiotensin converting enzyme 2 (ACE2), which raises levels of des-Arg(9)-bradykinin, a bioactive bradykinin metabolite associated with lung injury and inflammation. Mouse and rat both carry a Kng1 ortholog.
HMWK is essential for blood coagulation, whereas LMWK is not, so KNG1 products help to separate the roles of the two splice products.
HMWK is required for assembly of the kallikrein-kinin system and is the source from which bradykinin is released.
Bradykinin raises vascular permeability, stimulates nociceptors and prompts release of mediators such as prostaglandins.
Bradykinin affects vasodilation and blood pressure, and ACE2 depletion in SARS-CoV-2 infection raises des-Arg(9)-bradykinin linked to lung injury.
KNG1 encodes kininogens. HMWK is essential for blood coagulation and assembly of the kallikrein-kinin system, and bradykinin is released from it. Bradykinin affects smooth muscle contraction, blood pressure, vascular permeability and nociceptor stimulation, and acts as an antimicrobial peptide.
KNG1 is also known as BK, HMWK, KNG, BDK and HK, and was previously named kininogen. Alternative splicing produces high molecular weight kininogen and low molecular weight kininogen. Three transcript variants encoding different isoforms have been found. Check the datasheet of any product for its validated reactivity.
Mouse and rat each have a Kng1 ortholog. NCBI Gene notes that SARS-CoV-2 infection depletes ACE2, raising des-Arg(9)-bradykinin, a bradykinin metabolite associated with lung injury and inflammation.
Kallikrein-kinin system components, bradykinin receptors and coagulation-related targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P01042; product specifications from Assay Genie datasheets.